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Abstract
Fosfomycin (FOS) is an antibiotic used in pig farms for treatment and prevention of infections caused by resistant bacteria
during the post-weaning period. Antibiotics and non-toxic concentrations of mycotoxins, such as deoxynivalenol (DON) are
frequently found in the diet of animals. These compounds can establish interactions in the intestinal tract, which could
affect and/or modify the penetration of FOS to enterocytes. The aim of this study was to determine the penetration of FOS
into IPECJ-2 cells, a cell line derived from the small intestine of piglets, in the presence and absence of DON. The results from
this study showed that there was statistically significant difference in the intracellular concentration of FOS between cells
incubated with 580 mg/ml FOS and cells incubated with 580 mg/ml FOS and 1 mg/ml DON. The Cmax of the intracellular
antibiotic in the culture plates incubated with FOS in absence of DON was 45.81 mg/ml with a tmax of 4 h. When IPEC-2 cells
were incubated with FOS and DON the Cmax was 20.06 mg/ml and the tmax was 30 min. It is concluded that the non-toxic
concentration of DON on IPEC-J2 cells after short-term exposure, interferes with the pharmacokinetics of the antibiotic.
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Introduction
Fosfomycin (FOS), cis-1,2-epoxyphosphonic acid, is an antibac-
terial drug discovered in 1961. It has a low molecular weight
(138.059 Da) and its chemical structure is similar to that of
phosphoenol-pyruvate. However, two symmetrical phosphate
radicals, connected to a three carbon structure give this drug a
unique chemical structure unrelated to other antibacterial families
and no cross-resistance with other antibiotics has been reported
[1,2]. It has a wide spectrum antibacterial activity against gram-
positive and gram-negative bacteria [3,4,5,6]. Orally, FOS is used
in its calcium salt form. Calcium FOS has poor intestinal
absorption, reaching low concentrations in serum [7]. In clinical
practice, FOS represents a potential alternative for the treatment
of infections caused by resistant bacteria in weaning piglets [8]. On
the other hand, animals could be affected by the presence of anti-
nutritional compounds in the diet, for example, mycotoxins.
Deoxinivalenol (DON) belongs to the trichothecene family of
mycotoxins, which are produced by Fusarium sp., fungi that
commonly contaminate cereal grains, such as wheat and maize
[9]. DON is of major importance in animal feeding, mainly
because of its frequent occurrence in cereal grains, being porcine
the most sensitive species to the toxic effects of this mycotoxin
[10,11]. Roige´ et al. carried out a study to identify the mycotoxins
and mycobiota present in samples of wheat (as bran) and corn (as
dry grain or fermented feed), which are main ingredients of
feedstuffs used in cattle and pig farms in the South of Buenos Aires
Province, Argentina. Fusarium (47%) was the most frequent fungus
isolated from corn. DON was detected in 59% of corn samples, in
45% of wheat samples and in 38% of the silage samples [12]. In
Europe, DON is the most prevalent trichothecene in crop
production and it contaminates common cereal-based diets
[13,14].
Contaminations in the diet with high concentrations of DON
induce vomiting, diarrhea, immunosuppression and malabsorp-
tion of nutrients [15,16,17]. The mechanism of action of DON is
based on the inhibition of protein synthesis in the cells.
Furthermore, DON affects growth and function of intestinal
epithelial cells by several pathological mechanisms, including
activation of cellular signaling and ribosomal stress [18].
Following ingestion of DON-contaminated food and antibiotic
in the diet, the intestine is exposed to the interaction between both
compounds. The result of this interaction could adversely affect
the effectiveness of antibiotic by interfering with the penetration of
the drug into the enterocytes or by affecting intestinal absorption.
The integrity of the intestine allows efficient nutrient absorption,
acts as a physical barrier for pathogens and toxins and participates
in the innate immune response [19,20,21,22].
IPEC-J2 is a non-transformed columnar epithelial cell line
originated from the mid-jejunum of a neonatal piglet [23].
Recently, IPEC-J2 cells were used to demonstrate that high
concentrations of DON reduced the viability of porcine intestinal
epithelial cells, especially when applied basolaterally [11,24,25].
Consequently, IPEC-J2 cells are a good model for studying
whether the penetration of FOS into enterocytes may be affected
by the presence of low concentrations of DON in the diet. Given
the high homology in porcine and human intestinal structure and
function, and presumably in enterocytes as well [23,26], studies
performed with IPEC-J2 cells may provide valuable insights on the
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possible effects of interactions between mycotoxins and antibiotics
on human intestinal mucosa.
The aim of this study was to determine the penetration of FOS
into IPECJ-2 cells in the presence and absence of DON.
Materials and Methods
IPEC-J2 cells
IPEC-J2 cells were kindly provided by Dr. Anthony Blikslager
(North Carolina State University, Raleigh, NC) [27]. The cells
were cultured in Dulbecco’s modified Eagle medium: nutrient
mixture F-12 (Ham) (1:1) with GlutaMAXTM-I (DMEM/F12)
(Invitrogen TM Life Technologies, Carlsbad, CA, USA) supple-
mented with 20% fetal bovine serum, 1% insulin-transferring-
selenium supplements (Invitrogen), 1% epidermal growth factor
(Invitrogen) and 1% penicillin-streptomycin (penicillin 10,000 U/
ml and streptomycin 100 mg/ml; Invitrogen) in a humidified
atmosphere of 5% CO2 at 37uC. The cells were routinely seeded
at a density of 26105/ml with 5 ml medium in plastic tissue
culture flasks (25 cm2,Greiner Bio One, Frickenhausen, Germany)
and passaged every 4 days for a maximum of 4 times (IPEC-J2
passages 20-24).
IPEC-J2 cells were seeded into 24-well plates at a concentration
of 1.26105/ml in a final volume of 1 ml per well. Cells reached a
confluent monolayer within 4 days and were then used in all
experiments.
Cell exposure to antibiotic
IPEC-J2 cells were exposed to 580 mg/ml calcium FOS (98.9%
of purity; Bedson Laboratory, Pilar, Buenos Aires, Argentina).
This concentration was estimated based on the fact that in
weaning piglets, calcium FOS is administered at 30 mg/kg body
weight, thus the estimated total dose for a 15 kg-piglet is 450 mg.
Eighty percent of the administered drug remains in the gut [8].
Therefore, only 360 mg of FOS could reside in the gut. In
addition, because the intestinal volume of a 15 kg-piglet is 622 ml
[28], it is estimated that 580 mg of FOS can be found in each
milliliter of intestinal volume. In conclusion, it was determined that
the appropriate concentration of FOS to use in the assays was 580
ppm (mg/ml).
Cell exposure to mycotoxin
IPEC-J2 cells were exposed to 1 mg/ml DON with 580 mg/ml
calcium FOS. This concentration was determined starting from
low concentration of DON (less than 3 ppm DON in the diet)
[15]. For this experiment, it was assumed that DON is completely
bio-accessible and when ingested in one meal by a 15 kg-piglet
that consumes 800 g food/day, DON is diluted in 622 ml of
gastrointestinal fluid. Purified DON (D0156; 040M4062 Lot
Number; Sigma-Aldrich, Germany) was diluted in absolute
methanol grade H.P.L.C. (99.9%, SintorganH) to prepare a 1
ppm stock solution. At the time of performing the assays, tubes
with 1 ppm DON were evaporated to dryness and diluted with
antibiotic in isotonic saline before addition to the culture plates.
Intracellular penetration of fosfomycin
Three groups of cell cultures were used. Group I was constituted
by the IPEC-J2 cultures without antibiotic or mycotoxin (control
group). For Group II, cell culture plates were incubated with FOS
and for Group III, IPEC-J2 cells were incubated with a
combination of FOS and DON. The antibiotic and mycotoxin
were diluted in isotonic saline and were added to corresponding
cell culture plates at a concentration of 580 ppm and 1 ppm,
respectively. Cells in the control group were incubated with 1 ml
of isotonic saline. Cells were maintained in an atmosphere of 5%
CO2 at 37uC for different periods of time (0, 5, 10, 15 and 30 min,
1–4, 6, 8,12 and 24 h).
Cell viability
Cell concentration and viability were determined by trypan blue
exclusion assay in the three groups after 24 h of incubation of the
IPEC-J2 cells spiked with FOS and/or DON. The isotonic saline
with FOS or FOS plus DON from the culture plates was discarded
and tripsin was added to the cells. Once cells were detached, the
culture medium containing fetal bovine serum was added to the
wells in order to stop the activity of the trypsin. Aliquots of 10 ml of
cell suspension and 10 ml of 0.4% tripan blue solution were mixed.
The concentration and cell viability, (number of living cells/
number of total cells) x 100, were determined in a hemocytometer
Neubauer chamber under an optical microscope.
Extraction of fosfomycin
After incubation, cells were washed twice with 1 ml HPLC
water to eliminate the free antibiotic that was not taken up by the
cells. Then, 1 ml HPLC water was added to each well of the
culture plates. Cells were lysed by sonication for 30 min to release
the intracelullar antibiotic to the HPLC water. After centrifugation
at 10.000 rpm at 4uC for 6 min, the supernatant was filtered
through 0.22 m nylon filters, placed in vials and analyzed by high
performance liquid chromatography-mass-mass (HPLC MS-MS)
according to the method described by Soraci et al. [8]. The
HPLC-MS/MS system was from Thermo Electron Corporation
(San Jose, CA, USA), consisting of a Finnigan Surveyor auto
sampler, a Finnigan Surveyor MS quaternary pump. The detector
was a Thermo Quantum Discovery Max triple quadrupole mass
spectrometer, equipped with electrospray (ESI) ion source.
Nitrogen was used as nebulizer and sheath gas was obtained
through a nitrogen generator from Peak Scientific Ltd. (Inchinnan,
Scotland). Data processing was done using Xcalibur software, also
from Thermo. The mass spectrometer was operated in negative
ionization mode. The tuning parameters were optimized with
10 mg/ml individual aqueous solutions of fosfomycin directly
infused in the ion source by means of a syringe pump at 10 ml/
min, with influence of a mobile phase delivered from the LC pump
through a T connection to give the corresponding chromato-
graphic flow rate. The spray voltage was set to –3800 eV, the
capillary temperature was 350uC and argon 99.999% purity was
used for Collision Induced Dissociation (CID) at 1.6 m Torr in the
collision cell. Source CID energy was set to –8eV. Fosfomycin
detection and quantification were achieved by single reaction
monitoring of transitions m/z 137u R 79 with an optimized
collision energy of 25. Lower limit of quantification (LOQ) was
0.1 mg/ml, a parameter which was thoroughly studied by our
research group in different tissues of piglets, such as muscle, liver,
gut and kidney.
The average volume of IPEC-J2 cells was calculated by
multiplying the concentration of cells in each well of the culture
plates by the average volume of intracellular water in mononuclear
cells (3.75610-6ml) [29].
Statistical analysis
Data were analyzed by Student’s t test and p values were
calculated using SAS. Mean values represent triplicate measure-
ment of at least 3 independent experiments. Significant differences
between cells treated with FOS and cells treated with FOS and
DON were considered when p , 0.05.
Fosfomycin into IPEC-J2 Cells
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Results
Dead cells were not observed in the groups incubated with
isotonic saline (control group), with FOS and with FOS and DON
after 24 h of incubation. Differences in the percentage of cell
viability were not observed (p.0.05) between the groups. On the
other hand, the mean concentration of cells in each well of the
culture plates, as determined by trypan blue exclusion assay, was
0.96105 cells/ml for the three groups.
The concentrations of intracellular FOS detected by HPLC
MS-MS exceeded thoroughly the limit of quantification for this
drug. Furthermore, matrix effects were not observed during the
determination of FOS. The chromatogram in figure 1 shows the
high resolution and the peak shape obtained for the assays
performed with 580 ppm FOS and 1 ppm DON.
The comparison between the antibiotic group vs the antibiotic
and mycotoxin group allowed us to determine that DON produces
a significant effect in the penetration of FOS into the cells.
The maximum concentration (Cmax) of intracellular antibiotic in
the culture plates incubated with 580 mg/ml calcium FOS was
45.81. It was determined that the maximum concentration (tmax)
was reached after four hours of incubation. After this time, the
concentration of intracellular antibiotic decreased to 23.48 mg/ml
at 24 h of incubation. FOS slowly accumulated within IPEC-J2
cells and only 7.89% of the antibiotic was able to enter the cells.
Thus, most of the antibiotic remained in the extracellular fluid.
In the culture plates incubated with 580 mg/ml calcium FOS
and 1 mg/ml DON, the Cmax of intracellular FOS was 20.06 mg/
ml vs. 45.81 mg/ml in the plates incubated only with the antibiotic
(p,0.001). In the group incubated with both subtances, the Cmax
of intracellular FOS represented 3.46% in relation to the initial
concentration of FOS. The concentration of intracellular antibi-
otic decreased up to 2.31 mg/ml at 24 h of incubation. Another
important difference between both groups was the tmax. In the
presence of mycotoxin, the tmax was 30 min while in its absence,
the tmax was 4 h. In summary, the Cmax and tmax of FOS were
lower in cells treated with FOS plus DON. As shown in figure 2, a
significant effect of DON in the intracellular concentration of FOS
was observed.
Discussion
An important function of the gastrointestinal epithelium is to
provide a barrier against the penetration of food contaminants and
pathogens present in the intestinal lumen [30]. The disruption of
the intestinal barrier allows an increased penetration of normally
excluded luminal substances that may promote intestinal disorders
[31,32,33]. In addition, the alteration of the intestinal epithelium
interferes with the absorption of antibiotic. In the present study,
we demonstrated that the intracellular concentration of FOS in
IPEC-J2 cells decreased in the presence of low concentrations of
DON.
Clinical effects associated with DON ingestion in pigs include
feed refusal, weight loss, poor performance, gastrointestinal
irritation (such as diarrhea, colic and rectal prolapse), squamous
hyperplasia of the gastric lining and possible immunomodulation.
The DON dose affecting feed intake and rate of gain in swine
studies varied with the age of the pig, source of DON (purified
versus natural contamination) and exposure conditions (ad libitum
vs restrictive feeding and duration of exposure) [34]. Commonly,
effects of DON have not been found at levels from 0.6 to 1 mg
DON/kg feed [35]. For this experiment, the concentration of 1
ppm DON was established because it does not produce toxic
effects in vivo. Pollmann et al. observed in 8 kg-pigs that when
Figure 1. Intracellular concentration of FOS after treatment with 580 ppm FOS and 1 ppm DON in IPEC-J2 cells after 4 h of
incubation.
doi:10.1371/journal.pone.0075068.g001
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DON concentration was greater than 1 mg DON/kg in the diet,
the feed intake declined [36]. In addition, Bergsjo et al. fed 25 kg-
pigs a diet containing 2 and 4 mg DON/kg feed. The authors
determined a non-effect level based on feed intake, weight gain
and feed efficiency [37]. Furthermore, other reason to use 1 mg/ml
of DON was based on the Commission Recommendation 2006/
576/EC, which set down 0.9 mg/g of DON in complementary
and complete feeding stuff for pigs as guidance value [38].
Moreover, no toxic effect was observed in vitro when IPEC-J2 cells
were incubated with 1 mg/ml DON as determined by the trypan
blue exclusion assay in which cell death was not observed after 24
h of incubation with the mycotoxin. These results are consistent
with those observed by Vandenbroucke et al., who found that
1 mg/ml of DON was non-cytotoxic to differentiated IPEC-J2 cells
[39]. However, Danicke et al. and Diesing et al. demonstrated that
high concentrations of DON reduced the viability of porcine
intestinal epithelial cells, especially when applied basolaterally
[11,24,25].
FOS is a water soluble antibiotic, which is orally administered
despite its poor bioavailability (F: 2061.85% in pigs) [40]. The
intestinal absorption of FOS occurs through both a saturable
carrier-mediated mechanism and nonsaturable passive diffusion,
as it was determined in rats [41,42,43,44]. It is known that FOS
has a hydrophilic structure, thereby; the passage of the drug by
passive diffusion is not high [1,45,46,47,48]. An in situ intestinal
perfusion study showed that carrier-mediated transport via a Na+-
dependent phosphate (NaPi-II) is relevant, especially at concen-
trations of less than 1 mM FOS. The initial uptake of FOS was
inhibited by phosphate in a concentration–dependent manner. On
the other hand, an overshoot uptake of FOS was observed in the
presence of an inwardly direct Na+ gradient [49,50].
We have demonstrated in culture of HEp-2 cells that the
intracellular concentration of FOS is not significantly modified
when the cells are incubated with a concentration of 130 and
280 mg/ml FOS [51,52]. Our data suggest that the concentration
of 580 ppm FOS (. 1 mM) causes the saturation of this carrier
and that 7.89% of the antibiotic was able to enter the cells.
The phosphate transporter carriers are mainly located in
jejunum, being less active in ileum [49]. Therefore, FOS
absorption would be limited to these intestinal segments. The
saturable carrier-mediated mechanism of FOS transport across the
enterocyte may impact on the pulse therapy administration of
FOS in pig production. FOS is administered in pulse dosing in
water twice/day. The residence time of intestinal digest in the
FOS absorption site is only 3–4 h in pig [53]. Therefore, an
important FOS pulse dose is lost through feces (F: 2061.85%)
[40].
The FOS oral dosage in water for pigs should consider the oral
administration of small concentrations of the antibiotic along the
day (according to physiological intake of water) to avoid the
saturation of carrier phosphate. Beside, FOS is an antibiotic
classified as ‘‘time dependent’’ and thereby adaptable to this
method of administration [54].
It is known that DON affects epithelial protein synthesis and
function [55,56]. It has been demonstrated that DON affects the
activities of intestinal transporters such as the sodium-dependent
glucose/galactose transporter SGLT1, facilitated sugar transport-
ers GLUT and amino-acid transports [57]. Maresca et al. reported
that low concentrations (,10 mmol/L) of DON applied to human
intestinal epithelial cells selectively modulate the activities of
specific intestinal transporters, including the D-glucose and D-
galactose sodium-dependent transporter, SGLT-1 and D-fructose
transport GLUT5 [58]. Although it has not been demonstrated
that DON modifies the sodium-ion-dependent phosphate trans-
port which FOS uses to enter the cells, our findings suggest that
the lower intracellular concentration of FOS in presence of the
mycotoxin could be attributed to the effect of DON over these
mechanisms.
In conclusion, our results indicate that a non-toxic concentra-
tion of DON on cells after short-term exposure interferes with the
pharmacokinetic of FOS. Considering the frequent occurrence of
DON in cereal-based foods and feeds worldwide, the importance
of these findings should not be underestimated.
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Figure 2. Intracellular concentration of FOS in IPEC-J2 cells exposed to FOS or the combination of FOS and DON during 24 h. Data
are means of experiments performed in triplicate 6 SD.
doi:10.1371/journal.pone.0075068.g002
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